Journey Medical Corp (DERM) stock news · rev $61.9M
Journey Medical Corp (DERM) is a drug manufacturers - specialty & generic company listed on US.
This DERM news page leads with what Journey Medical Corp filed — not a scraped headline mill.
No cached 8-K sentence for DERM yet. We will not pad this page with generic market recap.
Latest reported DERM revenue for 2025-12-31 was $61.9M. Net income was -$11.4M. Revenue was up 10.2% from 2024-12-31 to 2025-12-31. DERM currently screens at market cap $163.1M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the DERM stock page; for the tape open the quote page.
DERM stock news FAQ
What are DERM's latest revenue and net income?
Latest cached Journey Medical Corp (DERM) revenue for Dec 31, 2025 was $61.9M. Net income was -$11.4M. Statements: https://lician.com/financials/derm
How did DERM revenue change from the prior cached period?
Cached Journey Medical Corp (DERM) revenue was up 10.2% from $56.1M (Dec 31, 2024) to $61.9M (Dec 31, 2025). Statements: https://lician.com/financials/derm
What is DERM's market cap?
Journey Medical Corp (DERM) market cap is $163.1M on the latest cached fundamentals snapshot.
What kind of company is DERM?
Journey Medical Corp (DERM) is a drug manufacturers - specialty & generic company listed on US.
Where is DERM stock news listed?
Cached stock news for Journey Medical Corp (DERM) is listed at https://lician.com/news/derm. Filings: https://lician.com/sec/derm
Not investment advice.